Data gathered: December 21
AI Stock Analysis - Ocean Biomedical (OCEA)
Analysis generated March 30, 2024. Powered by Chat GPT.
Ocean Biomedical is a company that operates in the biotech industry with a focus on developing innovative healthcare solutions. It aims to leverage cutting-edge research to tackle some of the most pressing medical challenges of our time. Given the dynamic nature of the biotech sector, Ocean Biomedical is potentially positioned at the forefront of medical breakthroughs, which could be reflected in its long-term financial performance and stock valuation.
Stock Alerts - Ocean Biomedical (OCEA)
 |
Ocean Biomedical | December 20 Price is down by -19.7% in the last 24h. |
|
Ocean Biomedical | December 18 Price is down by -5.2% in the last 24h. |
|
Ocean Biomedical | December 17 Price is up by 6.1% in the last 24h. |
|
Ocean Biomedical | December 16 Price is down by -6.8% in the last 24h. |
Alternative Data for Ocean Biomedical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 84 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Google Trends | 7 | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 106 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 60 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,653 | Sign up | Sign up | Sign up |
| Twitter Followers | 256 | Sign up | Sign up | Sign up |
| Twitter Mentions | 19 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 13 | Sign up | Sign up | Sign up |
About Ocean Biomedical
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer.
| Price | $0.66 |
| Target Price | Sign up |
| Volume | 9,140,000 |
| Market Cap | $26M |
| Year Range | $0.58 - $2.24 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Down 16.6% in NovemberDecember 1 - ETF Daily News |
 |
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QNovember 22 - Yahoo |
Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination LetterOctober 22 - GlobeNewswire |
|
Ocean Biomedical receives noncompliance letter from NasdaqOctober 21 - TipRanks |
|
Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors.October 15 - GlobeNewswire |
|
Ocean Biomedical, Molecure sign licensing agreement for YKL-40 inhibitorsOctober 14 - Thefly.com |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '23 | 0 | -640,000 | 140,000 | -17M | -16M | -0.487 |
| Q3 '23 | 0 | 2.4M | -2.9M | -14M | -14M | -0.530 |
| Q2 '23 | 0 | 2.7M | -4.2M | -13M | -11M | -0.390 |
| Q1 '23 | 0 | 12M | -27M | -67M | -72M | 0.430 |
| Q4 '22 | 7.8M | 780,000 | 7.1M | 410,000 | -610,000 | 0.031 |
Insider Transactions View All
| AJJARAPU SURENDRA K filed to buy 5,411,000 shares at $1. March 2 '23 |
Similar companies
Read more about Ocean Biomedical (OCEA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Ocean Biomedical?
The Market Cap of Ocean Biomedical is $26M.
What is the current stock price of Ocean Biomedical?
Currently, the price of one share of Ocean Biomedical stock is $0.66.
How can I analyze the OCEA stock price chart for investment decisions?
The OCEA stock price chart above provides a comprehensive visual representation of Ocean Biomedical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ocean Biomedical shares. Our platform offers an up-to-date OCEA stock price chart, along with technical data analysis and alternative data insights.
Does OCEA offer dividends to its shareholders?
As of our latest update, Ocean Biomedical (OCEA) does not offer dividends to its shareholders. Investors interested in Ocean Biomedical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Ocean Biomedical?
Some of the similar stocks of Ocean Biomedical are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.